Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Johnson & Johnson

JNJNYSE
Healthcare
Drug Manufacturers - General
$246.91
$0.00(0.00%)
U.S. Market is Open • 10:40

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap584.4B
P/E Ratio22.14
EPS (TTM)$11.02
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$250.55
3 Months$236.52
1 Year Target$174.56

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.29, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $174.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.14 and a market capitalization of 584.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.78%
5-Day Change
-0.85%
1-Month Change
11.14%
3-Month Change
19.42%
6-Month Change
35.60%
Year-to-Date (YTD) Change
16.96%
1-Year Change
51.87%
3-Year Change
53.49%
5-Year Change
49.82%
All-Time (Max) Change
19777.87%

Contact Information

732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

1,381,000 Employees
IPO DateJan 2, 1943
CountryUS
Actively Trading

Frequently Asked Questions